185 related articles for article (PubMed ID: 16193252)
1. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy.
Galeazzi GM; Ferrari S; Giaroli G; Mackinnon A; Merelli E; Motti L; Rigatelli M
Neurol Sci; 2005 Oct; 26(4):255-62. PubMed ID: 16193252
[TBL] [Abstract][Full Text] [Related]
2. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D
Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268
[TBL] [Abstract][Full Text] [Related]
3. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
Graystone HJ; Garner MJ; Baldwin DS
J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis, interferon beta-1b and depression A prospective investigation.
Feinstein A; O'Connor P; Feinstein K
J Neurol; 2002 Jul; 249(7):815-20. PubMed ID: 12140662
[TBL] [Abstract][Full Text] [Related]
5. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
Defer G
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional assessment of psychiatric disorders in renal transplantation patients in Turkey: a preliminary study.
Arapaslan B; Soykan A; Soykan C; Kumbasar H
Transplant Proc; 2004 Jun; 36(5):1419-21. PubMed ID: 15251349
[TBL] [Abstract][Full Text] [Related]
7. [Alexithymia and links with depression and anxiety in multiple sclerosis].
Chahraoui K; Pinoit JM; Viegas N; Adnet J; Bonin B; Moreau T
Rev Neurol (Paris); 2008 Mar; 164(3):242-5. PubMed ID: 18405774
[TBL] [Abstract][Full Text] [Related]
8. Depression in adults with intellectual disability: symptoms and challenging behaviour.
Hurley AD
J Intellect Disabil Res; 2008 Nov; 52(11):905-16. PubMed ID: 18680532
[TBL] [Abstract][Full Text] [Related]
9. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
Ayatollahi P; Nafissi S; Eshraghian MR; Kaviani H; Tarazi A
Mult Scler; 2007 Mar; 13(2):275-7. PubMed ID: 17439899
[TBL] [Abstract][Full Text] [Related]
10. Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment.
Moreau T; Schmidt N; Joyeux O; Bungener C; Souvignet V
Eur Neurol; 2009; 62(2):79-85. PubMed ID: 19521082
[TBL] [Abstract][Full Text] [Related]
11. Screening for mental disorders in cardiology outpatients.
Birket-Smith M; Rasmussen A
Nord J Psychiatry; 2008; 62(2):147-50. PubMed ID: 18569779
[TBL] [Abstract][Full Text] [Related]
12. Alexithymia in multiple sclerosis: relationship with fatigue and depression.
Bodini B; Mandarelli G; Tomassini V; Tarsitani L; Pestalozza I; Gasperini C; Lenzi GL; Pancheri P; Pozzilli C
Acta Neurol Scand; 2008 Jul; 118(1):18-23. PubMed ID: 18162056
[TBL] [Abstract][Full Text] [Related]
13. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
14. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2009 Mar; 15(3):385-92. PubMed ID: 19153176
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
16. Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis.
Solari A; Motta A; Mendozzi L; Aridon P; Bergamaschi R; Ghezzi A; Mancardi GL; Milanese C; Montanari E; Pucci E
Neurol Sci; 2004 Feb; 24(6):375-83. PubMed ID: 14767682
[TBL] [Abstract][Full Text] [Related]
17. Outcome and impact of mental disorders in primary care at 5 years.
Jackson JL; Passamonti M; Kroenke K
Psychosom Med; 2007 Apr; 69(3):270-6. PubMed ID: 17401055
[TBL] [Abstract][Full Text] [Related]
18. [The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients].
Ozcan M; Uğuz F; Cilli AS
Turk Psikiyatri Derg; 2006; 17(4):276-85. PubMed ID: 17183444
[TBL] [Abstract][Full Text] [Related]
19. Illness perception and health-related quality of life in multiple sclerosis.
Spain LA; Tubridy N; Kilpatrick TJ; Adams SJ; Holmes AC
Acta Neurol Scand; 2007 Nov; 116(5):293-9. PubMed ID: 17850407
[TBL] [Abstract][Full Text] [Related]
20. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis.
Chwastiak LA; Gibbons LE; Ehde DM; Sullivan M; Bowen JD; Bombardier CH; Kraft GH
J Psychosom Res; 2005 Nov; 59(5):291-8. PubMed ID: 16253619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
